Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates

Veracyte (VCYT) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 850%. A quarter ago, it was expected that this molecular diagnostic company would post a loss of $0.03 per share when it actually produced earnings of $0.30, delivering a surprise of 1,100%.Over the last four quarters, the co ...